Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free:

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site:, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Google Analytics

Targeted advertising cookies


The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at or by post at:

24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal logo Université Clermont Auvergne & associés

Human Nutrition Unit

Zone de texte éditable et éditée et rééditée

Didier Rémond


Research Activities       Publications       Curriculum Vitae

Research activities

According to INSEE projections, 1/3 of the French population will be over 60 in 2050. One of the features of ageing is sarcopenia, which is a physiological and involuntary loss of muscle mass and strength. This feature is common to all older individuals, including healthy ones, and is considered one of the most important causes of disability, frailty and morbidity. Preventing muscle mass and strength loss in elderly has thus become an important challenge in order to maintain their autonomy, health and welfare, but also to reduce public health care costs.

Age-related loss of muscle proteins can be worsen by a decreased arterial availability of nutrients. The amino acid bioavailability depends on the nature of ingested proteins and the food matrix in which they are, but also on the metabolic activity of the other body tissues competing with the muscle for their use. Among these competitors, tissues from the splanchnic area (gut and liver) play a key role. Any increased utilization of one or several amino acids by these organs will necessarily affect muscle protein anabolism. During the past ten years, my work in this area has been focused on the ‘Food matrix’ effect on nutrients bioavailability, and on the intestinal metabolism of specific amino acids (threonine et acides amines soufrés).

Up to 2050, the combined increase in world population, and standards of living in developing countries, will lead to a tremendous rise in the demand for food protein, especially animal-source protein (FAO, 2013). This demand cannot be met in a sustainable way by an increase in animal production, so that the use of alternative sources of protein must be considered.

Thus, my research program focuses now on the development of new protein food for overall or targeted populations (mainly seniors).To reach this goal, I currently work on the characterisation of the nutritional quality of alternative protein sources, on the impact of the technological processes associated with them, and finally on the validation of their health effects in human. As such, I am coordinating a national project on the valuing of plant proteins in blends of high nutritional quality, aiming at the prevention of metabolic dysregulations in the elderly population (ANR P-Probs).


-  Human nutrition: protein quality evaluation (amino acid composition, digestibility, digestion rate, bioactive peptides), impact of food processing on protein quality, amino acid metabolism in the gut, inter-organ fluxes of amino acids.

-  Experimental approaches: in vivo studies in human or animals (pig, minipig, rat), focussing on quantitative and dynamics measurements of digestive and blood fluxes of nutrients: 1/ surgical implantation of digestive cannula, and vascular catheters, 2/ measurement of the digestive and blood fluxes, 3/ investigation of protein metabolism with metabolic tracers, 4/ use of 15N labelled protein sources.

Dr Didier REMOND Publications

Read more

Dr Didier REMOND Parcours et Eléments de CV

Parcours et Eléments de CV
Read more